A new patient costs a practice somewhere between $150 and $400 in marketing before they ever sit in the chair [1]. An existing patient costs almost nothing to bring back — they already trust you, they've already been diagnosed, and many already have insurance approval in hand. Yet most growth plans start with the expensive option.
Where the production actually is
Three pools of production sit inside almost every independent practice. None of them requires finding anyone new.
The benchmarks worth knowing
- Case acceptance. The average practice accepts about 45% of presented treatment; top performers reach around 75% [2]. The gap between the two is almost entirely follow-through.
- Unscheduled treatment. A typical practice has 30–60% of its diagnosed treatment sitting unscheduled at any given time [3].
- Hygiene reappointment. Keeping recare reappointment above 85% is a common target; below 75% means a meaningful share of active patients is quietly becoming inactive [4].
- Hygiene share of production. Hygiene typically accounts for about 25% of total production, with strong practices at 30–33% [4].
Five levers that don't require a single new patient
- Work the approved-but-unscheduled list first. These patients have already agreed to care. Sort by value and by age — the longer an approval sits, the less likely it converts.
- Protect the hygiene schedule. Reappoint every recare patient before they leave, and fill cancellations with the most valuable care first.
- Use benefits before they reset. Patients with remaining benefits and diagnosed treatment are the easiest conversations of the year — especially in Q4.
- Make every visit productive. A crown seat or a post-op check produces nothing on its own. If that patient is due for other covered care, the same visit can do more.
- Follow up like it matters. Most patients who don't schedule never hear from the practice again. A personal, specific follow-up changes that.
StackFloss